Payor Strategy Framework for Health System CFOs

Jim Giordano, Managing Director, Payor Solutions
Warbird Healthcare Advisors

Hospital operating margins remain under relentless pressure. The American Hospital Association (AHA) reported that in 2023 more than half of U.S. hospitals finished the year with negative operating margins, and median operating margin for the sector hovered near 1.5 percent, a level insufficient to sustain the capital investment required to serve patients, train clinicians, and modernize infrastructure.^[1]

Meanwhile, commercial payors, whose combined medical loss ratios remain among the lowest in a decade, are deploying increasingly sophisticated payment-avoidance tactics: prior authorization expansion, retrospective claim audits, downcoding, and algorithmic denial engines that exploit documentation gaps at scale. AHLA has documented a marked increase in payor disputes, and HFMA's 2024 revenue cycle survey found that denial rates across commercial lines have climbed to an average of 11 percent of submitted claims, up from 9 percent just three years prior.^[2]

Against this backdrop, many health systems still manage payor relationships the way they did 20 years ago: contract-by-contract, at renewal, reactive, and in organizational silos. The results are predictable: rate concessions made without a clear understanding of market position, yield leakage from contracts that perform below their negotiated terms, and an unchecked erosion of the earned revenue that every department, service line, and patient access initiative depends on.^[3]

The foundation of any effective payor strategy is a rigorous, data-driven assessment of three interrelated questions: How is each contract actually performing relative to what was negotiated? How do our contracted rates compare to market? And what is each payor truly costing us to serve?

Contract Yield Analysis
Most health systems have access to their claims and remittance data, yet remarkably few have built the analytical infrastructure to systematically compare actual reimbursement against expected payment at the claim level. This gap (the difference between what a payor should pay under a contract and what they actually pay) is yield leakage. At scale, even modest leakage compounds quickly: a 2 percent underpayment rate on $500 million in commercial gross revenue represents $10 million in annual margin erosion that rarely appears on anyone's dashboard.^[4]

A proper yield analysis requires mapping every remittance to its corresponding contractual obligation: rate schedules, fee schedules, carve-outs, stop-loss provisions, outlier payment thresholds, and coordination of benefits rules. The delta between expected and actual payment by payor, by service line, and by claim type is the diagnostic output that drives both operational recovery (claim appeals, zero-pay queues) and strategic repositioning at the negotiating table.

Rate Benchmarking vs. Market
The Consolidated Appropriations Act of 2021 and subsequent CMS price transparency regulations have fundamentally changed what health systems can know about their competitive rate position. Hospital price transparency data (now available from virtually every U.S. hospital through machine-readable files) combined with the Sage Transparency and RAND Hospital Price Transparency datasets, allows sophisticated analytics teams to benchmark contracted rates against both Medicare multiples and commercial peer rates in the same market.^[5]

RAND's 2023 report on hospital prices found that commercial prices averaged 254 percent of Medicare rates nationally, with wide regional variation, from below 200 percent in some markets to above 350 percent in others. Health systems whose contracted rates fall materially below these benchmarks are leaving value on the table; those above them carry defensible data into renewal conversations. Either way, you cannot negotiate market parity without knowing where you stand.^[6]

Cost-to-Serve and Administrative Burden Analysis
A dimension of payor analytics that remains chronically undervalued is the administrative cost each payor imposes. CAQH's 2023 Index estimated that the U.S. healthcare industry spends $61.8 billion annually on administrative complexity, of which providers bear the majority. Prior authorization alone costs the average hospital $35,000 per physician per year in administrative staff time.^[7]

When payor contracts are evaluated purely on rate, low-rate payors with high administrative burden—complex prior auth requirements, high denial rates, slow payment cycles—may appear more profitable than they are. A comprehensive diagnostic model layers cost-to-serve onto rate analysis to produce a true contribution margin view of the payor portfolio.

The Portfolio Lens: Book of Business vs. Contract-by-Contract
Perhaps the most significant analytical shift a health system can make is moving from contract-level evaluation to a portfolio view. This means assessing the payor mix holistically; understanding the volume, acuity, and contribution margin of each payor's membership not just for hospital facilities but simultaneously for the physician enterprise. Facility and physician contracts are often negotiated separately, with separate teams, separate timing, and separate data—yet payors manage them as a single book. Health systems that align facility and physician strategy create natural leverage points: bundled performance obligations, combined rate positioning, and unified governance that payors must engage with comprehensively.

Payor negotiation is fundamentally a leadership challenge before it is an analytical one. Without internal alignment, even the most sophisticated rate analytics will fail at the table. Payors are extraordinarily skilled at exploiting organizational fragmentation—physician leadership concerns, service line sensitivities, board-level risk tolerance gaps—to neutralize leverage and extract concessions. The answer is governance: a structured, standing decision-making architecture that creates alignment before negotiations begin and accountability after they conclude.[8]

The Executive Managed Care Steering Committee
The cornerstone of internal governance is an Executive Managed Care Steering Committee (MCSC): a standing body with the authority and membership to make enterprise-level decisions about payor strategy, contract approvals, risk tolerance, and portfolio positioning. The MCSC is not a working group or a committee of directors. It is C-suite: the CEO or President, CFO, General Counsel/Compliance, CMO, and select campus or service line leadership, supported by the VP of Managed Care and VP of Revenue Cycle in advisory roles.

The MCSC meets monthly, with quarterly deep-dives on portfolio performance. It governs through a Contract Evaluation Playbook: a structured, four-gate decision framework that assesses every major payor agreement through four lenses:

Strategic Fit: Does this contract advance our service line strategy, network position, and market objectives
Financial/Risk: Does the rate structure and risk allocation meet margin thresholds? What is the yield expectation vs. actual performance history
Operational/Clinical: Can we deliver the quality commitments required? What prior auth and utilization management obligations are imposed
Legal/Compliance: Are the terms defensible? What indemnification, audit rights, and administrative requirements are we accepting?

ACHE's 2023 CEO survey identified payor relationships as the third-most-significant strategic concern among health system executives, trailing only workforce and financial sustainability. Yet fewer than 40 percent of respondents reported having a formal governance structure for managed care strategy. The absence of governance is itself a strategic vulnerability.[9]

Payor-Facing Governance Venues
Governance is not only internal. The most durable payor relationships are structured through formal bilateral operating venues—Joint Operating Committees (JOCs) and AR Workgroups—that create standing accountability outside the contract renewal cycle.

Joint Operating Committees (JOCs)
A JOC is a senior-level forum (VP and above on both sides) that meets quarterly to review performance, address escalations, and discuss strategic alignment. JOC agendas should include: aggregate claim volume and payment trends, denial rate trends by category, prior authorization approval rates and turnaround times, quality and value-based performance updates, and any emerging contract interpretation disputes. The JOC is the relationship venue where rapport is built, goodwill is deposited, and systemic issues are resolved before they become litigation or termination threats.

AR Workgroups
Below the JOC sits the AR Workgroup: an operational accountability forum led by VP Revenue Cycle and VP Managed Care, meeting monthly with payor counterparts. AR Workgroups review specific denial categories, payment posting discrepancies, escalated claim appeals, and systematic underpayment trends. This is where the diagnostic data from Pillar 1 becomes a live accountability mechanism: payor payment avoidance behaviors that show up in analytics are brought to the table with specificity, and resolution timelines are tracked and reported to the JOC.

Together, the MCSC, JOCs, and AR Workgroups create a three-tier governance hierarchy with clear escalation pathways: AR Workgroup → JOC → MCSC. This structure ensures that operational issues never quietly fester, and that strategic decisions are made with full awareness of frontline performance reality.

Most payor negotiations begin from a position of weakness: a rate increase request made on or near the contract expiration date, without a structured understanding of leverage, without a market-grounded position, and without the governance backing to hold a firm line. The result is predictable: the payor controls the conversation and the outcome.

Effective negotiation strategy begins with a deliberate leverage inventory: what does this payor need from us, and what do we uniquely offer that cannot be easily replaced?

Health System Sources of Leverage

Network Adequacy: State and federal network adequacy standards require payors to maintain minimum provider-to-member ratios and geographic access standards. A health system with market-dominant primary care, specialty access, or geographic coverage that a payor cannot replicate from other networks holds meaningful leverage—but must know it and be willing to use it.
Quality and Value-Based Performance: Health systems with strong quality ratings, low readmission rates, and documented outcomes superiority can reframe negotiations around total cost of care, not just unit rate. CMS quality data, HEDIS measures, and CMS Star ratings provide the evidence base.
Administrative Friction Cost Imposed on Payors: High denial rates, disputes, audit activity, and escalation volume all impose cost on payors that sophisticated health system teams can quantify and surface. A payor spending significant administrative resources managing disputes with a single provider has financial incentive to resolve the underlying contract issues.
Market Dynamics and Competitive Alternatives: In markets where alternative payor partners exist (regional plans, Medicare Advantage growth, Medicaid managed care) the credible threat of redirecting referral volume or renegotiating panel participation changes the payor's calculus.

Understanding Payor Priorities
Effective negotiators understand what the other party needs to say yes. Payors are managing their own pressures: state network adequacy regulations, CMS Medicare Advantage Star rating requirements that link to reimbursement benchmarks, medical cost trend management targets, and member retention in competitive markets. A health system that frames its negotiating position in terms that address payor needs reduced administrative friction in exchange for rate relief, quality improvement commitments in exchange for reduced prior authorization scope, or multi-year stability in exchange for favorable rate escalators—achieves durable agreements rather than one-cycle wins.^[10]

Chargemaster Optimization as a Strategic Tool
One dimension of payor strategy that deserves specific attention is Chargemaster (CDM) optimization—the systematic evaluation of gross charges relative to a multiple of Medicare. Most commercial payor contracts are structured as a percentage of billed charges for some service categories, making the CDM a direct driver of reimbursement for those lines. Additionally, payor contract rate negotiations for percent-of-billed-charge arrangements are directly influenced by the multiple of Medicare represented in the CDM.^[11]

A CDM that has not been systematically reviewed and optimized—comparing the Medicare multiple for both inpatient and outpatient service lines against regional benchmarks—is leaving money on the table in every contract that references billed charges. CDM optimization is not a coding compliance risk when done properly; it is a defensible, data-driven exercise that strengthens the rate foundation underlying commercial contracts.

Designing Win-Win Negotiation Outcomes
The most durable payor agreements are not zero-sum wins. They are structured exchanges in which both parties achieve meaningful objectives: the health system achieves market-rate reimbursement and reduced administrative burden; the payor achieves network stability, quality performance, cost predictability, and regulatory compliance. Multi-year frameworks with CPI-linked or Medicare-benchmarked rate escalators, simplified prior authorization protocols for high-performing service lines, and joint quality improvement commitments: these are the building blocks of agreements that do not need to be relitigated every two years.

The most sophisticated payor strategy in the world will underperform if it is not operationalized through the revenue cycle. Managed Care sets the terms; Revenue Cycle lives the consequences. Yet in most health systems, these functions operate in separate reporting structures, with separate data, separate tools, and separate performance metrics—a structural misalignment that costs health systems real money every day.

The Cost of Disconnection

When contract terms are not correctly loaded into the contract management system (fee schedules with effective dates, carve-out definitions, outlier payment methodologies) every claim processed under those terms produces payment variance. Some of that variance is overpayment; most is underpayment. HFMA estimates that between 3 and 5 percent of net revenue is lost annually through underpayment and under-recovery—a figure that in a $2 billion net revenue health system represents $60 to $100 million in annual leakage.^[12]

Denials are the most visible symptom of payor/revenue cycle disconnection. When denial patterns (clinical, coding, authorization, timely filing) are not surfaced to Managed Care leadership with the specificity needed to drive payor-level accountability, they become chronic. The payor's denial engine continues operating without consequence. AI-powered denial management platforms are beginning to change this dynamic: tools that analyze claim-level data in real time, identify payor payment avoidance patterns, predict denial likelihood at the point of scheduling or coding, and route appeals intelligently are now demonstrating measurable impact on net revenue recovery.^[13]

What Each Function Brings to the Partnership

Managed Care → Revenue Cycle

Contract term intelligence: fee schedules, rate structures, policy attachments, and amendment history—loaded correctly and updated in real time
Payor escalation authority: when denial or underpayment patterns violate contract terms, Managed Care can activate the JOC and AR Workgroup channels to demand remediation
Early warning on policy changes: payor bulletins, medical policy updates, and network changes that will affect operational workflows before they hit the claim level

Revenue Cycle → Managed Care

Real-world performance data: actual denial rates, underpayment amounts, timely filing losses, and payor-specific abrasion patterns—the evidence base for JOC agendas and contract negotiations
Cost-to-serve quantification: the administrative labor cost of managing each payor's requirements (authorization, billing edits, appeal work) expressed in dollars per claim or per dollar collected
Payor payment avoidance intelligence: AI-generated pattern analysis identifying systematic behaviors (downcoding clusters, authorization retrodenials, claim splitting) that are demonstrably inconsistent with contract terms

The Role of AI in Enabling the Partnership

Artificial intelligence is transforming the revenue cycle from a reactive claims-processing function into a proactive payor performance management capability. Machine learning models trained on historical claim, authorization, and remittance data can now identify denial risk at the point of service, flag likely underpayments before remittance posting, and surface systematic payor behaviors that manual audit processes would never detect at scale. For Managed Care leaders, AI-generated payor intelligence provides precisely the kind of specific, evidence-based documentation needed to bring payor payment avoidance to the JOC and AR Workgroup with accountability—and to the negotiating table with leverage.^[14]

The four pillars described above are not sequential steps. They are components of an ongoing operating model: a continuous cycle in which diagnostic intelligence informs governance decisions, governance alignment creates negotiating leverage, leverage produces better agreements, and better agreements are operationalized through a Revenue Cycle partnership that generates the next round of diagnostic intelligence.

For health system CFOs, the imperative is clear:

Invest in the analytical infrastructure to know where you stand (on rate, on yield, on cost-to-serve, and on market position) before you sit down at the table.
Build the governance architecture (MCSC, JOCs, AR Workgroups) that gives your team the institutional backing and the payor-facing accountability structures to hold a principled position.
Train your Managed Care leadership to negotiate as value partners, not rate supplicants; bringing market data, quality evidence, and mutual interest framing to every conversation.
Close the gap between Managed Care and Revenue Cycle with shared data, shared metrics, and shared accountability for contract performance from signature to remittance.

Health systems that build this capability will not simply negotiate better contracts. They will manage payor relationships as the strategic asset they are, one that when properly governed and analytically grounded, can yield meaningful margin improvement even in an environment where every other cost lever is constrained.[15]

Sources and References

[1] American Hospital Association (AHA). “The Financial State of the Hospital Field — 2024 Update.” AHA, 2024. https://www.aha.org/guidesreports/2024-financial-state-hospital-field
[2] Healthcare Financial Management Association (HFMA). “2024 Healthcare Revenue Cycle Survey.” HFMA, 2024. https://www.hfma.org/industry-initiatives/revenue-cycle-survey/
[3] American Health Law Association (AHLA). “Payer-Provider Disputes: Trends and Strategies.” AHLA, 2023. https://www.healthlawyers.org
[4] Crowe LLP. “Health System Revenue Cycle Denials Index.” Crowe, 2023. https://www.crowe.com/healthcare
[5] Centers for Medicare & Medicaid Services (CMS). “Hospital Price Transparency Final Rule.” CMS, 2021. https://www.cms.gov/hospital-price-transparency; Sage Transparency. https://sagetransparency.com
[6] RAND Corporation. “Deviation of Commercial Hospital Prices from Medicare Prices.” RAND Health Quarterly, 2023. https://www.rand.org/pubs/research_reports/RRA1820-1.html
[7] CAQH. “2023 CAQH Index: Closing the Gap — The Industry’s Opportunity to Modernize Healthcare Administration.” CAQH, 2023. https://www.caqh.org/sites/default/files/explorations/index/2023-caqh-index.pdf
[8] Becker’s Hospital Review / Advisory Board. “Managed Care Strategy in a Shifting Payer Landscape.” 2023.
[9] American College of Healthcare Executives (ACHE). “2023 Top Issues Confronting Hospitals Survey.” ACHE, 2023. https://www.ache.org/learning-center/research/about-the-field/top-issues-confronting-hospitals
[10] KFF (Kaiser Family Foundation). “Medicare Advantage in 2024: Enrollment Update and Key Trends.” KFF, 2024. https://www.kff.org/medicare/issue-brief/medicare-advantage-in-2024
[11] CMS. “2024 Medicare Physician Fee Schedule Final Rule.” CMS, 2023. https://www.cms.gov/medicaremedicare-fee-service-paymentphysicianfeeschedpfs-federal-regulation-notices
[12] Healthcare Financial Management Association (HFMA). “Understanding Revenue Integrity and Net Revenue Recovery.” HFMA Revenue Cycle Forum, 2023.
[13] Advisory Board. “The State of Healthcare AI: Revenue Cycle Applications.” Advisory Board Research, 2024.
[14] McKinsey & Company. “Artificial Intelligence in Revenue Cycle Management.” McKinsey Health Systems & Services, 2024.
[15] American Hospital Association (AHA). “Strategic Payer Contracting: A Framework for Financial Sustainability.” AHA Resource Library, 2023.

Rethinking Payor Strategy: In Defense of Margin Integrity

A Thought Leadership Perspective for Health System CFOs, VP’s of Managed Care, and Chief Revenue Officers

Diagnostic Tools

You cannot negotiate what you cannot measure

Governance

Alignment is leverage

Leverage & Negotiation

From rate ask to value exchange

Partnership

Managed care and revenue cycle partnership: closing the loop

Pillar 1: Diagnostic Tools: You Cannot Negotiate What You Cannot Measure

Pillar 2: Governance: Alignment is Leverage

Pillar 3: Governance (Leverage and Negotiation) From Rate Ask to Value Exchange

Pillar 4: The Managed Care / Revenue Cycle Partnership: Closing the Loop

The Cost of Disconnection

What Each Function Brings to the Partnership

The Role of AI in Enabling the Partnership

The Integrated Model: A Continuous Cycle

The pressure from payors isn't going away

Sources and References